Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Cardiologist compensation still rising, especially in invasive and interventional cardiology
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
AHA issues a scientific statement on COVID-19 cardiac arrhythmias
The objective of the AHA scientific statement is to review the available evidence on for better management of cardiac arrhythmias from COVID causes that are still encountered on a regular basis.
Cardiologists perform world’s first substernal lead extraction
The 49-year-old patient was not in pain or suffering any complications, but he wished to have his extravascular ICD removed once his symptoms improved. The care team agreed to extract it after a long discussion, and they said it was "easier than expected."
Medtronic’s OmniaSecure, the smallest ICD lead of its kind, linked to long-term durability
Reliability modeling suggests the small-diameter defibrillation lead, already linked to positive early outcomes, should last patients for at least 10 years—and likely longer.
Rising heart failure, AFib rates a ‘wake-up call’ for US cardiologists
Today's heart teams already face a number of challenges on a day-to-day basis. New data suggest they could soon be treating more patients than ever before.

Boston Scientific Announces Positive European Registry Results For WATCHMAN Left Atrial Appendage Closure Device

MARLBOROUGH, Mass., May 12, 2017 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced positive safety and efficacy rates of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry presented during a late-breaking clinical trial session at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions in Chicago. Data confirmed that the WATCHMAN device had a high implant success rate and was effective in stroke reduction for patients with non-valvular atrial fibrillation (AF), including those patients deemed unsuitable for oral anticoagulation.

May 12, 2017

Heart Rhythm Society announces late-breaking clinical trials for annual conference

The Heart Rhythm Society (HRS) recently announced the late-breaking clinical trials sessions for the upcoming Heart Rhythm scientific sessions.

May 4, 2017

Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK Health Organizations

iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the recent publication of two documents in support of extended continuous ambulatory monitoring for arrhythmia detection.

April 10, 2017

Researchers Dig for Data to Reduce Disparities in Atrial Fibrillation Treatment

Black people with atrial fibrillation (AF) experience vastly higher rates of serious coronary events, so it’s not surprising that a growing number of clinical studies are aggressively tackling the complex issues around the impact of race—as well as gender—on management and outcomes of the heart rhythm disorder.

January 30, 2017

Medtronic agrees to operate cath, EP labs at Cleveland medical center

Medtronic has signed a deal to operate the catheterization and electrophysiology laboratories at the University Hospitals Cleveland Medical Center in Cleveland.

November 30, 2016

Abbott, St. Jude Medical agree to sell vascular closure, electrophysiology assets

Abbott and St. Jude Medical announced Oct. 18 that the companies agreed to sell a portion of their vascular closure and electrophysiology business for $1.12 billion to Terumo Corporation.

October 19, 2016

ICD’s Incongruity: Same-day Discharge Safe But May Not Cost Less

Trial results on same-day discharge for elective implantable cardioverter-defibrillator procedures may reassure centers, but whether the approach lowers cost is anyone’s guess.

October 4, 2016

University of Chicago Medicine Creating High-Tech Arrhythmia Technology Suite with Stereotaxis Niobe® ES System

July 13, 2016 — Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the University of Chicago Medicine will implement the Company’s Niobe ES remote magnetic navigation system as part of its vision to create a cutting-edge arrhythmia technology suite.

July 15, 2016

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Electrophysiology

Cardiologist compensation still rising, especially in invasive and interventional cardiology

AHA issues a scientific statement on COVID-19 cardiac arrhythmias

Cardiologists perform world’s first substernal lead extraction

Medtronic’s OmniaSecure, the smallest ICD lead of its kind, linked to long-term durability

Rising heart failure, AFib rates a ‘wake-up call’ for US cardiologists

Around the web